Innovation Center ● Prof. Dr. med. habil. David Pittrow
Real World Evidence
DIRECTOR
Prof. Dr. med. habil. David Pittrow
3P Consulting
Höhenweg 13
82229 Seefeld
Phone +49 8152 99 89 803
Fax +49 8152 99 89 805
E-mail pittrow@3p-consulting.com
Short Vita
Professional background:
- 2005 - today GWT-TUD
- Member of the Steering Committee, Study Director / Principal Investor in the following studies (selection): EPOSS-OMERACT, DETECT, getABI, COMPERA, ReDuCTO, SIGNS, INSIGHTS-IPF, INSIGHTS-SVT, FIGARO, SENEQA, RAHPP, PERY-DYS, EXPLAIN-IRON, CORE CUVITRU, EXPERT, EXPOSURE, DePorED, INSIGHTS-ILD, INSIGHTS-GHT and others.
- 2008 - 2012 Co-founder and Managing Director MBiotec GmbH, Seefeld
- 2001 - today Founder and Managing Director of 3P Consulting, Seefeld
Scientific career:
- Since 2010 Associate Professor, Faculty of Medicine, TU Dresden
- 2005 - 2010 Private lecturer, Faculty of Medicine, TU Dresden
- 2004 Habilitation in experimental clinical pharmacology (Dr. med. habil.)
- 1994 license to practice medicine (Bavarian Medical Association)
Research and development
- Consulting and expertise for non-interventional studies.
- Development of study designs in the field of observational studies and drug safety studies (PASS).
- Development of observation plans
- Creation of validated study databases according to high quality standards
- Data management, statistical planning and evaluation
- Medical Writing according to STROBE Statement
- Preparation of publications and congress contributions
Expertise
- Pharmacoepidemiology and real-world evidence studies.
- Project planning and management of NIS, registry studies, PASS, surveys.
Reference projects
Numerous projects have already been successfully implemented in the Pharmacoepidemiology Innovation Center.
Some of them can be viewed below.